Marc L. A. Decramer
Impact in
- Pulmonary and Respiratory Medicine top 0.01%
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Respiratory Support and Mechanisms
- Respiratory and Cough-Related Research
- Inhalation and Respiratory Drug Delivery
- Neonatal Respiratory Health Research
- Issues, ethics and legal aspects top 0.05%
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 233
- Respiratory Support and Mechanisms 122
- Respiratory and Cough-Related Research 15
- Neonatal Respiratory Health Research 13
- Physiology 81
- Asthma and respiratory diseases 55
- Co-authors
- Rik Gosselink (84 shared papers)Thierry Troosters (44 shared papers)Wim Janssens (50 shared papers)Thierry Troosters (34 shared papers)Ghislaine Gayan‐Ramirez (70 shared papers)Donald P. Tashkin (28 shared papers)Fabio de Oliveira Pitta (16 shared papers)Bartolomé R. Celli (24 shared papers)
- Journals
- European Respiratory Journal (51 papers)American Journal of Respiratory and Critical Care Medicine (44 papers)Respiratory Medicine (29 papers)Journal of Applied Physiology (21 papers)CHEST Journal (17 papers)
- Partner nations
- BelgiumUnited StatesUnited Kingdom
In The Last Decade
Marc L. A. Decramer
388 papers receiving 31.5k citations
Marc L. A. Decramer's Hit Papers
Peers
Comparison fields: 5 of 187
- Pulmonary and Respiratory Medicine 22.9k
- Issues, ethics and legal aspects 449
- Physiology 7.4k
- Critical Care and Intensive Care Medicine 1.3k
- Complementary and alternative medicine 1.9k
Countries citing papers authored by Marc L. A. Decramer
This map shows the geographic impact of Marc L. A. Decramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc L. A. Decramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc L. A. Decramer more than expected).
Fields of papers citing papers by Marc L. A. Decramer
This network shows the impact of papers produced by Marc L. A. Decramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc L. A. Decramer. The network helps show where Marc L. A. Decramer may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc L. A. Decramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 394 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary Hit paper breakdown → | 2017 | 2553 |
| 2 | A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease Hit paper breakdown → | 2008 | 1745 |
| 3 | Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force Hit paper breakdown → | 1995 | 1325 |
| 4 | Characteristics of Physical Activities in Daily Life in Chronic Obstructive Pulmonary Disease Hit paper breakdown → | 2005 | 1008 |
| 5 | An Official American Thoracic Society/European Respiratory Society Statement: Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease Hit paper breakdown → | 2014 | 844 |
| 6 | Chronic obstructive pulmonary disease Hit paper breakdown → | 2012 | 836 |
| 7 | Peripheral Muscle Weakness Contributes to Exercise Limitation in COPD Hit paper breakdown → | 1996 | 835 |
| 8 | Early exercise in critically ill patients enhances short-term functional recovery* Hit paper breakdown → | 2009 | 786 |
| 9 | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary Hit paper breakdown → | 2017 | 723 |
| 10 | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary Hit paper breakdown → | 2017 | 553 |
| 11 | Physical Activity and Hospitalization for Exacerbation of COPD Hit paper breakdown → | 2006 | 547 |
| 12 | Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial Hit paper breakdown → | 2005 | 523 |
| 13 | Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report Hit paper breakdown → | 2017 | 523 |
| 14 | 2005 | 488 | |
| 15 | Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD Hit paper breakdown → | 2014 | 483 |
| 16 | Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey Hit paper breakdown → | 2002 | 479 |
| 17 | Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study Hit paper breakdown → | 2013 | 441 |
| 18 | Minimal Clinically Important Differences in Pharmacological Trials Hit paper breakdown → | 2014 | 407 |
| 19 | Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial Hit paper breakdown → | 2009 | 398 |
| 20 | 2009 | 394 |
About Marc L. A. Decramer
Marc L. A. Decramer is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Complementary and alternative medicine, Endocrine and Autonomic Systems and Issues, ethics and legal aspects, having authored 394 papers that have together received 33.0k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (233 papers), Respiratory Support and Mechanisms (122 papers), Asthma and respiratory diseases (55 papers), Cardiovascular and exercise physiology (30 papers), Neuroscience of respiration and sleep (20 papers), Respiratory and Cough-Related Research (15 papers), Neonatal Respiratory Health Research (13 papers) and Delphi Technique in Research (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (22.9k citations), Issues, ethics and legal aspects (449 citations), Physiology (7.4k citations), Critical Care and Intensive Care Medicine (1.3k citations) and Complementary and alternative medicine (1.9k citations). Marc L. A. Decramer has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Rik Gosselink, Thierry Troosters, Wim Janssens, Thierry Troosters, Ghislaine Gayan‐Ramirez, Donald P. Tashkin, Fabio de Oliveira Pitta, Bartolomé R. Celli, Steven Kesten and Vanessa Suziane Probst. Their work appears in journals such as European Respiratory Journal, American Journal of Respiratory and Critical Care Medicine, Respiratory Medicine, Journal of Applied Physiology and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.